- Location
- Bob Bell Auditorium, 6th Floor, Room 6-604, Princess Margaret Cancer Centre (in-person registration not required)
- Series/Type
- Alumni Event, DLSPH Partner & Affiliate Event, Faculty/Staff Event, Student Event
- Format
- Hybrid
- Dates
- September 8, 2025 from 12:30pm to 1:30pm
Links
Presented by the Canadian Institutes of Health Research (CIHR) Institute of Cancer Research, Dalla Lana School of Public Health (DLSPH) and University Health Network (UHN) Princess Margaret Cancer Centre…
Join Dr. Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC), as she discusses IARC’s evolving research and prevention strategies for the global cancer burden.
This event is co-hosted by:
- Dr. Fei-Fei Liu, Scientific Director, CIHR Institute of Cancer Research
- Dr. Adalsteinn (Steini) Brown, Dean, Dalla Lana School of Public Health
Speaker’s Bio:
Elisabete Weiderpass, MD, MSc, PhD, is Director of the International Agency for Research on Cancer (IARC), the World Health Organization’s specialized cancer agency, based in Lyon, France. She took office in January 2019 and, in May 2023, was elected for a second five-year term, commencing on 1 January 2024.
Dr. Weiderpass is an expert in cancer epidemiology and cancer prevention, with a particular interest in cancer registration, the understanding of cancers and the implementation of effective prevention strategies. She has published more than 1,000 scientific papers in peer-reviewed international journals. She is a member of the EU Mission Board for Cancer, Co-Chair of the Gustave Roussy Scientific Council, a member of the Governing Council of INSERM, a member of the Scientific Council of the Centre Léon Bérard, a Steering Committee member of the WHO Academy and, since 2025, a member of the French National Academy of Medicine (Académie Nationale de Médecine).
Prior to joining IARC, Dr. Weiderpass served as Head, Department of Research at the Cancer Registry of Norway, and of the Genetic Epidemiology Group at the Folkhälsan Research Center in Finland. She was Professor of Medical Epidemiology at the Karolinska Institutet in Stockholm, Sweden, and Professor of Cancer Epidemiology at the Arctic University of Norway. She has held visiting professorship positions in cancer epidemiology in Brazil, China, the Islamic Republic of Iran, and Kuwait and is an honorary Adjunct Professor at the Yale School of Public Health in the USA.